You are using an outdated browser. Please upgrade your browser to improve your experience.
Syngenta has acquired Intrinsyx Bio, a California-based start-up specializing in the development of nutrient use efficiency products.
This strategic move aligns with Syngenta's goal to reinforce its position as global leader in the biologicals business, enhancing farmers’ toolbox with additional assets to manage their crops effectively and sustainably.
This acquisition is aimed at accelerating the development and deployment of cutting-edge nutrient use efficiency (NUE) solutions by combining Intrinsyx Bio's innovative technology and pipeline with Syngenta's global R&D and commercial capabilities.
Intrinsyx Bio develops products focused on Nutrient Use Efficiency (NUE), including the Syngenta biological seed treatment NUELLO® iN. The company's products are currently commercialized in the US, UK, Benelux, and Iberia, with plans for expansion into other markets. This acquisition provides Syngenta, that has now full access to Intrinsyx Bio’s portfolio, with a strong platform to build a world-leading position in NUE, the fastest-growing market segment in biologicals.
The acquisition represents a significant step forward in Syngenta’s commitment to shaping a new era of agriculture, and reflect Syngenta’s commitment to helping agriculture achieve higher yields with lower environmental impact – a core pillar of Syngenta Group’s Sustainability Priorities.